Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marisa Goff"'
Autor:
Daniel W. Heindel, Dania M. Figueroa Acosta, Marisa Goff, Clauvis Kunkeng Yengo, Muzafar Jan, Xiaomei Liu, Xiao-Hong Wang, Mariya I. Petrova, Mo Zhang, Manish Sagar, Phillip Barnette, Shilpi Pandey, Ann J. Hessell, Kun-Wei Chan, Xiang-Peng Kong, Benjamin K. Chen, Lara K. Mahal, Barbara A. Bensing, Catarina E. Hioe
Publikováno v:
iScience, Vol 27, Iss 8, Pp 110390- (2024)
Summary: Bacteria dysbiosis and its accompanying inflammation or compromised mucosal integrity is associated with an increased risk of HIV-1 transmission. However, HIV-1 may also bind bacteria or bacterial products to impact infectivity and transmiss
Externí odkaz:
https://doaj.org/article/e5305c3f335e45a9a5819c9e033eed91
Autor:
Daniel Heindel, Dania Figueroa Acosta, Marisa Goff, Muzafar Jan, Xiao-Hong Wang, Mariya Petrova, Kun-Wei Chan, Xiang-Peng Kong, Benjamin Chen, Lara Mahal, Barbara Bensing, Catarina Hioe
While bacterial dysbiosis has been associated with increased HIV-1 transmission risk, little is known about direct associations between HIV-1 and bacteria. This study evaluated HIV-1 interactions with bacteria through glycan-binding lectins that affe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6753c0f431cfc0ba15c89b7870f17259
https://doi.org/10.21203/rs.3.rs-2596269/v1
https://doi.org/10.21203/rs.3.rs-2596269/v1
Publikováno v:
Science
GPER1 in utero to the rescue! Several common pathogens, including influenza A virus (IAV), can activate systemic type I interferon (IFN) signaling during pregnancy. Such infections would be expected to cause birth defects and fetal mortality, but mat
Autor:
Jeffrey J. Tarrand, Dimitrios P. Kontoyiannis, Jean K. Lim, Marisa Goff, Nathaniel D. Albert, Michail S. Lionakis, Muthulekha Swamydas, Prema Robinson, Sebastian Wurster
Publikováno v:
J Infect Dis
Pharmacological immune checkpoint blockade has revolutionized oncological therapies, and its remarkable success has sparked interest in expanding checkpoint inhibitor therapy in infectious diseases. Herein, we evaluated the efficacy of programmed cel
Autor:
Yiming Cai, Maya Modak, Sebastian Weigang, Emmie de Wit, Jean K. Lim, Alistair Dunham, Benjamin J. Polacco, Qiongyu Li, Svenja Ulferts, Gwendolyn M. Jang, Aurelien Dugourd, David E. Gordon, Jeffrey Z. Guo, Kirsten Obernier, Sophia Bouhaddou, Elizabeth R. Fischer, Anna Gaulton, Jason C.J. Chang, Bjoern Meyer, Diego Quintero, Julian Knerr, Trupti Patil, Emma J. Manners, Michael C. O’Neal, Monita Muralidharan, Joseph Hiatt, Ajda Rojc, James E. Melnyk, Tanja Kortemme, Benjamin R. tenOever, Thomas Vallet, Rémy Robinot, Cassandra Koh, Benjamin E. Nilsson-Payant, Ruth Hüttenhain, Saker Klippsten, Alicia L. Richards, Eloy Felix, Brian K. Shoichet, Beril Tutuncuoglu, Danielle L. Swaney, Veronica V. Rezelj, Jeffery R. Johnson, Margaret Soucheray, Marisa Goff, R. Dyche Mullins, Kris M. White, Erica Stevenson, Jyoti Batra, Christopher J.P. Mathy, Yuan Zhou, Minkyu Kim, Marco Vignuzzi, Claudia Hernandez-Armenta, Kevan M. Shokat, Julio Saez-Rodriguez, Jacqueline M. Fabius, Timothy McBride, Adolfo García-Sastre, Quang Dinh Tran, Alexandra Hardy, Elena Moreno, Alberto Valdeolivas, Mehdi Bouhaddou, Andrew R. Leach, Melanie Ott, Georg Kochs, Pedro Beltrao, Jiewei Xu, Robyn M. Kaake, Merve Cakir, Ying Shi, Nevan J. Krogan, Lisa Miorin, Danish Memon, David J. Broadhurst, Miguel Correa Marrero, Robert Grosse
Publikováno v:
Cell
Cell, vol 182, iss 3
Cell, Elsevier, 2020, 182, pp.685-712.e19. ⟨10.1016/j.cell.2020.06.034⟩
Cell, 2020, 182 (3), pp.685-712.e19. ⟨10.1016/j.cell.2020.06.034⟩
Cell, vol 182, iss 3
Cell, Elsevier, 2020, 182, pp.685-712.e19. ⟨10.1016/j.cell.2020.06.034⟩
Cell, 2020, 182 (3), pp.685-712.e19. ⟨10.1016/j.cell.2020.06.034⟩
Summary The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed hundreds of thousands of people worldwide, highlighting an urgent need to
Autor:
Jenny Ahn, Christina Davidian, James Ramirez, Daniel Lozano, Justin E. Miller, Marisa Goff, Sara D'Souza, Jeffrey H Miller, Raechel Subandi
Publikováno v:
Antimicrobial agents and chemotherapy, vol 63, iss 2
We show that trimethoprim (TMP), an antibiotic in current use, displays a strong synergistic effect on mutagenesis in Escherichia coli when paired with the base analog 2-aminopurine (2AP), resulting in a 35-fold increase in mutation frequencies in th
Autor:
Christina Davidian, Zhiyuan Mao, Karen Lam, Madeline Yung, Marisa London, Jeffrey H Miller, Lisa Yun Song, Marisa Goff
Publikováno v:
Antimicrobial agents and chemotherapy, vol 60, iss 10
We examined the mutagenic specificity of the widely used antibiotic ciprofloxacin (CPR), which displays weak to moderate mutagenic activity in several bacteria and generates short in-frame deletions in rpoB in Staphylococcus aureus . To determine the